Echo Therapeutics, a startup company with a prototype skin permeation technology, collaborated with Farm in the development of a safe, painless, and needle-free alternative to traditional drug delivery therapies and non-invasive glucose monitoring. Echo’s device allows clinicians to permeate the outermost protective layer of the skin and is intended for use in hospital critical care units.